The enhanced national pharmacovigilance system implemented for COVID-19 vaccines in France: A 2-year experience report.
Crommelynck S, Grandvuillemin A, Ferard C, Mounier C, Gault N, Pierron E, Jacquot B, Vaillant T, Chatelet IPD, Jacquet A, Salvo F, Alt M, Bagheri H, Micallef J, Pariente A, Gautier S, Valnet-Rabier MB, Atzenhoffer M, Lepelley M, Cottin J, Lacroix I, Gras V, Massy N, Dhanani A, Vella P, Shaim Y, Baril L, Jonville-Béra AP, Benkebil M; 30 French Regional Pharmacovigilance Centres.
Crommelynck S, et al. Among authors: benkebil m.
Therapie. 2024 Nov 14:S0040-5957(24)00199-9. doi: 10.1016/j.therap.2024.11.002. Online ahead of print.
Therapie. 2024.
PMID: 39638686